Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults older than 18 years of age
- People who are able to give their informed consent to participate
- People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by tissue testing)
- People whose prostate cancer has continued to grow or spread despite having very low testosterone levels (known as castration-resistant prostate cancer)
- People whose scans show fewer than 10 areas of cancer spread outside the brain
- People who have been receiving a systemic treatment (a medication that works throughout the body) for more than 3 months
- People where all areas of cancer spread are in locations that doctors can safely treat with a targeted form of radiation called SBRT
- People with a general health and activity level that falls within a certain range as measured by a standard medical scale (ECOG score of 0–3, meaning anywhere from fully active to capable of limited self-care — confirm with trial site)
Who may not be able to join:
- People who have signs that cancer is pressing on the spinal cord
- People for whom radiation therapy is not considered safe or suitable for medical reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rachel Glicksman, MD, Princess Margaret Cancer Centre - University Health Network
Phone: 416-946-4501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Study Feasibility; Change in Prostate-Specific Antigen (PSA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.